US14070B3096
US14070B3096
Capricor Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | 22.270.465 | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 108.142.130 | 64.833.707 | 66.8% | |
| Operating Income | -108.142.130 | -42.563.242 | 154.1% |
| Pretax Income | -105.042.346 | -40.465.586 | 159.6% |
| Net Income Common Stockholders | -105.043.946 | -40.467.186 | 159.6% |
| -- | -- | -- | |
| -- | -- | -- |